Diadenosine polyphosphates cause contraction and relaxation in isolated rat resistance arteries.

The effects of diadenosine polyphosphates (APnA; n = 3-6) and adenine nucleotides on contractile reactivity of isolated rat mesenteric resistance arteries (MrA) and superior epigastric arteries (SEA), which display a dense and sparse autonomic innervation, respectively, were evaluated. All agonists examined, except adenosine and AMP, induced contractions. The rank order of potency was similar in both arteries: alpha,beta-methylene ATP (alpha,beta-meATP) > AP5A > AP6A > AP4A > ATP > ADP > AP3A. Contractions were stable during several minutes in SEA but highly transient in MrA. They were reduced after exposure to 10 microM alpha,beta-meATP and by 10 microM of the P2X antagonist pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid. During phenylephrine (10 microM)-induced contractions, the agonists induced a further contraction in SEA. In MrA, however, further contraction was followed by marked relaxation. The rank order of relaxing potency was comparable to that of the contractile potency of agonists. Also, the relaxing effects of APnA were blunted by 10 microM pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid and after exposure to alpha,beta-meATP. In vitro and in vivo sympathectomy with 6-hydroxydopamine and removal of the endothelium did not modify the effects of APnA in MrA. Thus, the contractile effects of APnA in resistance arteries 1) are due to a P2X purinoceptor-mediated stimulation of the smooth muscle; 2) depend on the length of the phosphate chain; and 3) are followed by endothelium-independent relaxing effects in MrA but not SEA, which may involve receptors that are similar to those mediating contraction. The regional heterogeneity of APnA effects cannot be attributed to a direct neurogenic influence.

[1]  K. Rahn,et al.  Heterogenous vascular effects of AP5A in different rat resistance arteries are due to heterogenous distribution of P2X and P2Y(1) purinoceptors. , 2000, The Journal of pharmacology and experimental therapeutics.

[2]  K. Okada,et al.  Clinical application of diadenosine tetraphosphate(Ap4A:F‐1500) for controlled hypotension , 1999, Acta anaesthesiologica Scandinavica.

[3]  K. Rahn,et al.  Effects of Diadenosine Polyphosphates on Systemic and Regional Hemodynamics in Anesthetized Rats , 1998, Kidney and Blood Pressure Research.

[4]  H. Schlüter,et al.  Diadenosine polyphosphates' action on calcium and vessel contraction. , 1997, American journal of hypertension.

[5]  J. Nishimura,et al.  Diadenosine polyphosphates directly relax porcine coronary arterial smooth muscle. , 1997, The Journal of pharmacology and experimental therapeutics.

[6]  J. Smits,et al.  Angiotensin II induces media hypertrophy and hyperreactivity in mesenteric but not epigastric small arteries of the rat. , 1997, Journal of vascular research.

[7]  G. Reiser,et al.  Characterization of [35S]‐ATPαS and [3H]‐α,β‐MeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations , 1997 .

[8]  C. Kennedy,et al.  The interaction of diadenosine polyphosphates with P2X‐receptors in the guinea‐pig isolated vas deferens , 1997, British journal of pharmacology.

[9]  H. Schlüter,et al.  Differential effects of diadenosine phosphates on purinoceptors in the rat isolated perfused kidney , 1997, British journal of pharmacology.

[10]  G. Janssen,et al.  α1-Adrenoceptor subtypes in rat aorta and mesenteric small arteries are preserved during left ventricular dysfunction post-myocardial infarction , 1997 .

[11]  H. Schlüter,et al.  Diadenosine polyphosphates increase cytosolic calcium and attenuate angiotensin-II-induced changes of calcium in vascular smooth muscle cells. , 1996, Journal of vascular research.

[12]  G. Burnstock,et al.  P2X purinoceptors in the feline pulmonary vascular bed: distribution and selective in vivo pharmacological probes. , 1996, The American journal of physiology.

[13]  R. Andriantsitohaina,et al.  Calcium handling and purinoceptor subtypes involved in ATP‐induced contraction in rat small mesenteric arteries. , 1996, The Journal of physiology.

[14]  P. Vallance,et al.  Effect of diadenosine phosphates on human umbilical vessels: novel platelet-derived vasoconstrictors. , 1995, British journal of clinical pharmacology.

[15]  G. Burnstock,et al.  Pivotal role of phosphate chain length in vasoconstrictor versus vasodilator actions of adenine dinucleotides in rat mesenteric arteries. , 1995, The Journal of physiology.

[16]  G. Burnstock,et al.  Comparative studies on the affinities of ATP derivatives for P2X‐purinoceptors in rat urinary bladder , 1994, British journal of pharmacology.

[17]  N. Lozovaya,et al.  Possible functional role of diadenosine polyphosphates: Negative feedback for excitation in hippocampus , 1994, Neuroscience.

[18]  H. Schlüter,et al.  Diadenosine phosphates and the physiological control of blood pressure , 1994, Nature.

[19]  J. Pintor,et al.  Ap4A and ADP‐β‐S binding to P2 purinoceptors present on rat brain synaptic terminals , 1993, British journal of pharmacology.

[20]  M. A. Moro,et al.  Diadenosine Tetraphosphate Is Co‐Released with ATP and Catecholamines from Bovine Adrenal Medulla , 1992, Journal of neurochemistry.

[21]  H. Bäumert,et al.  PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. , 1992, European journal of pharmacology.

[22]  R. Busse,et al.  Potent effects of AP3A and AP4A on coronary resistance and autacoid release of intact rabbit hearts. , 1991, The American journal of physiology.

[23]  P. Leff,et al.  Characterization of P2x‐receptors in rabbit isolated ear artery , 1990, British journal of pharmacology.

[24]  M. Mulvany,et al.  Structure and function of small arteries. , 1990, Physiological reviews.

[25]  R. Busse,et al.  Vasomotor activity of diadenosine triphosphate and diadenosine tetraphosphate in isolated arteries. , 1988, The American journal of physiology.

[26]  J. Lüthje,et al.  Catabolism of Ap4A and Ap3A in whole blood. The dinucleotides are long-lived signal molecules in the blood ending up as intracellular ATP in the erythrocytes. , 1988, European journal of biochemistry.

[27]  J. Lüthje,et al.  Catabolism of Ap4A and Ap3A in human serum. Identification of isoenzymes and their partial characterization. , 1987, European journal of biochemistry.

[28]  H. Bohlen.  Localization of vascular resistance changes during hypertension. , 1986, Hypertension.

[29]  G. Burnstock,et al.  Potent vasoconstrictor actions of α,β-methylene ATP, a stable analogue of ATP, on the rat vasculature, in vivo , 1985 .

[30]  D. Brutsaert,et al.  Mechanical Properties of Resting and Active Isolated Coronary Arteries , 1984, Circulation research.

[31]  K. Paigen,et al.  A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.

[32]  K. Hermsmeyer,et al.  Trophic influence of the sympathetic nervous system on the rat portal vein. , 1977, Circulation research.

[33]  J. D. De Mey,et al.  A positive and reversible relationship between adrenergic nerves and alpha-1A adrenoceptors in rat arteries. , 1998, The Journal of pharmacology and experimental therapeutics.

[34]  G. Reiser,et al.  Characterization of [35S]-ATP alpha S and [3H]-alpha, beta-MeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations. , 1997, British journal of pharmacology.

[35]  A. Sillero,et al.  Diadenosine 5',5"-P1,P4-tetraphosphate (Ap4A), ATP and catecholamine content in bovine adrenal medulla, chromaffin granules and chromaffin cells. , 1994, Biochimie.

[36]  G. Burnstock,et al.  Heterogeneous distribution of [3H]alpha,beta-methylene ATP binding sites in blood vessels. , 1993, Journal of vascular research.

[37]  A. J. Man in 't Veld,et al.  Determination of catecholamines in human plasma by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection. , 1989, Journal of chromatography.

[38]  M. Cipolla,et al.  A new method for mechanically denuding the endothelium of small (50-150 microns) arteries with a human hair. , 1989, Blood vessels.

[39]  G Burnstock,et al.  Is there a basis for distinguishing two types of P2-purinoceptor? , 1985, General pharmacology.

[40]  G. Burnstock,et al.  Potent vasoconstrictor actions of alpha, beta-methylene ATP, a stable analogue of ATP, on the rat vasculature, in vivo. , 1985, Acta physiologica Scandinavica.